Xanthone Derivatives: New Insights in Biological Activities
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
2517-2538
Author(s):
M. M.M. Pinto, M. E. Sousa and M. S.J. Nascimento
Ligand-Targeted Liposomes for Cancer Treatment
Journal:
Current Drug Delivery
Volume:
2
Page:
369-381
Author(s):
Puja Sapra, Pradeep Tyagi and Theresa M. Allen
Cannabinoids and Cancer
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
5
Page:
941-952
Author(s):
Natalya M. Kogan
Editorial [Hot Topic: New Approaches to Treating Cancer: Medicinal Chemistry and Therapeutic Potential (Guest Editor: David J. Weber)]
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1091-1092
Author(s):
David J. Weber
Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1151-1170
Author(s):
James F. Curtin, Gwendalyn D. King, Marianela Candolfi, Remy B. Greeno, Kurt M. Kroeger, Pedro R. Lowenstein and Maria G. Castro
PNP Anticancer Gene Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
1259-1274
Author(s):
Yang Zhang, William B. Parker, Eric J. Sorscher and Steven E. Ealick
Endothelin-1 and Angiogenesis in Cancer
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
309-314
Author(s):
Jonathan Knowles, Marilena Loizidou and Irving Taylor
Cannabinoids
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
507-530
Author(s):
Franjo Grotenhermen
Anti-Cancer/Anti-Tumor
Journal:
Current Bioactive Compounds
Volume:
1
Page:
109-132
Author(s):
Bentham Science Publishers
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
393-419
Author(s):
Christian Hafner, Albrecht Reichle and Thomas Vogt